{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["14"],"submitter":["Skalniak A"],"pubmed_abstract":["<h4>Introduction</h4>The standard care of schizophrenia patients is based on the assessment of their psychotic behavior, using interview-based, subjective scales that measure symptoms severity. We aimed at defining easily accessible and inexpensive blood-derived clinical diagnostic parameters that might serve as objective markers in the prediction of the effects of pharmacological treatment of schizophrenia patients.<h4>Methods</h4>A total of 40 patients with schizophrenia diagnosis according to ICD 10 during psychotic decompensation were included in the study. Blood-based biochemical parameters, BMI and interview-based medical scales of symptom severity were determined - all at admission and after 12 weeks of standard pharmacological treatment.<h4>Results</h4>The drops in scale values wer"],"journal":["Frontiers in psychiatry"],"pagination":["1082135"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10073498"],"repository":["biostudies-literature"],"pubmed_title":["Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment."],"pmcid":["PMC10073498"],"pubmed_authors":["Pilecki M","Donicz P","Smierciak N","Krzysciak W","Szwajca M","Skalniak A","Kozicz T"],"additional_accession":[]},"is_claimable":false,"name":"Immunological routine laboratory parameters at admission influence the improvement of positive symptoms in schizophrenia patients after pharmacological treatment.","description":"<h4>Introduction</h4>The standard care of schizophrenia patients is based on the assessment of their psychotic behavior, using interview-based, subjective scales that measure symptoms severity. We aimed at defining easily accessible and inexpensive blood-derived clinical diagnostic parameters that might serve as objective markers in the prediction of the effects of pharmacological treatment of schizophrenia patients.<h4>Methods</h4>A total of 40 patients with schizophrenia diagnosis according to ICD 10 during psychotic decompensation were included in the study. Blood-based biochemical parameters, BMI and interview-based medical scales of symptom severity were determined - all at admission and after 12 weeks of standard pharmacological treatment.<h4>Results</h4>The drops in scale values wer","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-05T12:18:30.249Z","creation":"2025-04-05T12:18:30.249Z"},"accession":"S-EPMC10073498","cross_references":{"pubmed":["37032951"],"doi":["10.3389/fpsyt.2023.1082135"]}}